|
Blood DNA Methylation Biomarkers of Alzheimers Disease |
1 R01 AG066179-01A1 |
ALISCH, REID SPENCER |
NIA |
2020 |
|
Mapping Molecular and Phenotypic Interactions in Alzheimers Disease |
1 R01 AG066490-01 |
MONTGOMERY, STEPHEN BLAIR |
NIA |
2020 |
|
Effects of Orally Administered Nicotinamide Riboside on Bioenergetic Metabolism, Oxidative Stress and Cognition in Mild Cognitive Impairment and Mild Alzheimers Dementia |
1 R01 AG066670-01 |
DU, FEI |
NIA |
2020 |
|
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease |
1 R01 AG066707-01 |
CHENG, FEIXIONG |
NIA |
2020 |
|
Finding combinatorial drug repositioning therapy for Alzheimers disease and related dementias |
1 R01 AG066749-01 |
JIANG, XIAOQIAN |
NIA |
2020 |
|
Pain in community-based older African American Adults: The Jackson Heart Study |
1 R01 AG066914-01A1 |
NEOGI, TUHINA |
NIA |
2020 |
|
Microglia antigen presentation in the CNS of Alzheimers disease |
1 R01 AG067581-01 |
ELYAMAN, WASSIM |
NIA |
2020 |
|
EGFR signaling in osteoarthritis and treatment |
1 R01 AG067698-01A1 |
QIN, LING |
NIA |
2020 |
|
Biobehavioral basis of knee osteoarthritis pain |
1 R01 AG067757-01 |
CRUZ-ALMEIDA, YENISEL |
NIA |
2020 |
|
Pharmacologic Inhibition of PDE11A for Age-Related Memory Disorders |
1 R01 AG067836-01 |
ROTELLA, DAVID |
NIA |
2020 |